IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAH1. A total of 19 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $590,063 | -92.1% | 577,000 | -90.9% | 0.01% | -89.4% |
| Q1 2022 | $7,438,494 | -12.0% | 6,333,000 | -15.0% | 0.05% | -6.0% |
| Q4 2021 | $8,454,708 | +185.4% | 7,450,000 | +204.1% | 0.05% | +127.3% |
| Q3 2021 | $2,962,555 | +7597.1% | 2,450,000 | +7105.9% | 0.02% | – |
| Q1 2021 | $38,489 | -98.5% | 34,000 | -98.5% | 0.00% | -100.0% |
| Q4 2020 | $2,502,527 | -50.9% | 2,201,000 | -57.2% | 0.02% | -64.3% |
| Q3 2020 | $5,098,000 | – | 5,146,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAMDEN ASSET MANAGEMENT L P /CA | 45,423,000 | $45,517,071 | 1.52% |
| READYSTATE ASSET MANAGEMENT LP | 12,500,000 | $12,588,392 | 1.17% |
| Wellesley Asset Management | 11,936,000 | $11,930,151 | 0.88% |
| WOLVERINE ASSET MANAGEMENT LLC | 36,774,000 | $37,005,818 | 0.44% |
| SHENKMAN CAPITAL MANAGEMENT INC | 2,935,000 | $2,926,917 | 0.22% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 12,674,000 | $12,763,623 | 0.06% |
| Calamos Advisors LLC | 9,500,000 | $9,495,440 | 0.05% |
| AQR Arbitrage LLC | 1,250,000 | $1,258,839 | 0.04% |
| Leucadia National | 2,747,000 | $2,776,791 | 0.02% |
| Citadel Advisors | 52,687,000 | $53,014,449 | 0.01% |